Kronos Bio Inc (KRON)
0.97
-0.03
(-3.00%)
USD |
NASDAQ |
May 23, 16:00
0.9012
-0.07
(-7.09%)
After-Hours: 06:36
Kronos Bio Shareholders Equity (Quarterly): 136.97M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 136.97M |
| December 31, 2023 | 159.08M |
| September 30, 2023 | 178.62M |
| June 30, 2023 | 203.34M |
| March 31, 2023 | 225.60M |
| December 31, 2022 | 244.50M |
| September 30, 2022 | 267.69M |
| June 30, 2022 | 292.24M |
| March 31, 2022 | 317.02M |
| Date | Value |
|---|---|
| December 31, 2021 | 345.10M |
| September 30, 2021 | 399.02M |
| June 30, 2021 | 424.11M |
| March 31, 2021 | 445.26M |
| December 31, 2020 | 465.52M |
| September 30, 2020 | -76.28M |
| June 30, 2020 | 84.93M |
| December 31, 2019 | -23.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-76.28M
Minimum
Sep 2020
465.52M
Maximum
Dec 2020
240.56M
Average
244.50M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 4.826M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.98M |
| Total Liabilities (Quarterly) | 46.01M |
| Current Ratio | 8.321 |